Ibritumomab (Anti-CD20)
Ibritumomab (anti-CD20) is a monoclonal antibody targeting anti-CD20 used to treat B-cell non-Hodgkin’s lymphoma. MW: 144.52 KD.
| Catalog Number | A2896 |
| CAS# | 206181-63-7 |
| Size | 1mg*5 |
Ibritumomab (anti-CD20) is a monoclonal antibody targeting anti-CD20 used to treat B-cell non-Hodgkin’s lymphoma. MW: 144.52 KD.
| Catalog Number | A2896 |
| CAS# | 206181-63-7 |
| Size | 1mg*5 |